Revance Therapeutics, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals: Major
  • ISIN: US7613301099
USD
3.65
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
-151.60
12.60
68.47
374.29
225.49
145.62
Shareholder's Funds
-151.60
12.60
68.47
374.29
225.49
145.62
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
437.45
384.29
285.38
184.96
6.42
0.00
Secured Loans
437.45
384.29
285.38
184.96
6.42
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Other Long Term Liabilities
114.24
114.24
114.77
104.44
73.82
48.76
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
540.83
493.62
395.40
284.97
73.82
48.76
Current Liabilities
Trade Payables
13.81
4.55
10.60
12.66
8.01
8.43
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
89.22
75.68
67.29
60.96
40.98
31.97
Total Liabilities
478.45
581.90
531.16
720.22
340.29
226.35
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
0.00
96.35
92.33
66.62
58.15
28.42
Less: Accumulated Depreciation
0.00
28.59
23.33
19.49
16.87
13.97
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
90.21
67.75
69.00
47.13
41.29
14.45
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
6.87
6.05
5.05
3.44
0.73
0.73
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
0.32
1.69
8.70
1.33
1.67
3.25
Total Non-Current Assets
139.59
207.17
285.05
270.22
43.69
18.43
Current Assets Loans & Advances
Current Investments
116.59
231.74
114.45
102.95
118.95
102.56
Inventories
45.58
18.32
10.15
5.88
0.00
0.00
Sundry Debtors
27.68
11.34
3.35
1.83
0.00
27.00
Cash and Bank
137.88
108.97
110.62
333.56
171.16
73.26
Other Current Assets
327.72
370.37
238.57
444.21
290.11
202.81
Short Term Loans and Advances
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Assets
338.87
374.73
246.12
450.00
296.60
207.92
Net Current Assets (Including Current Investments)
249.64
299.04
178.83
389.04
255.62
175.95
Total Current Assets Excluding Current Investments
338.87
374.73
246.12
450.00
296.60
207.92
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
478.45
581.90
531.16
720.22
340.29
226.35
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
437.45
384.29
285.38
184.96
6.42
0.00
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Dec 2023 is 12.45% vs 35.19% in Dec 2022

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Dec 2023 is 0.00% vs -0.46% in Dec 2022

stock-summary

Fixed Assets

YoY Growth in year ended Dec 2023 is 33.15% vs -1.81% in Dec 2022

stock-summary

Investments

YoY Growth in year ended Dec 2023 is 13.55% vs 19.80% in Dec 2022

stock-summary

Current Assets

YoY Growth in year ended Dec 2023 is -9.57% vs 52.25% in Dec 2022

Compare Balance Sheet Results of Revance Therapeutics, Inc.
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
-151.60
697.02
-848.62
-121.75%
Shareholder's Funds
-151.60
697.02
-848.62
-121.75%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
437.45
1.63
435.82
26,737.42%
Secured Loans
437.45
1.63
435.82
26,737.42%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
0
0
0.00
0.00%
Other Long Term Liabilities
114.24
0.72
113.52
15,766.67%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
540.83
0.72
540.11
75,015.28%
Current Liabilities
Trade Payables
13.81
7.70
6.11
79.35%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
89.22
24.78
64.44
260.05%
Total Liabilities
478.45
722.51
-244.06
-33.78%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
0
11.17
-11.17
-100.00%
Less: Accumulated Depreciation
0
6.27
-6.27
-100.00%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
90.21
4.90
85.31
1,741.02%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
6.87
0.56
6.31
1,126.79%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
0.32
0.13
0.19
146.15%
Total Non-Current Assets
139.59
5.59
134.00
2,397.14%
Current Assets Loans & Advances
Current Investments
116.59
645.77
-529.18
-81.95%
Inventories
45.58
0
45.58
0.00%
Sundry Debtors
27.68
0
27.68
0.00%
Cash and Bank
137.88
58.58
79.30
135.37%
Other Current Assets
327.72
704.35
-376.63
-53.47%
Short Term Loans and Advances
0
0
0.00
0.00%
Total Current Assets
338.87
716.93
-378.06
-52.73%
Net Current Assets (Including Current Investments)
249.64
692.15
-442.51
-63.93%
Total Current Assets Excluding Current Investments
338.87
716.93
-378.06
-52.73%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
478.45
722.51
-244.06
-33.78%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
437.45
1.63
435.82
26,737.42%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Borrowings 426.60 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 12.45% vs 35.19% in Dec 2022

Annual - Other Long Term Liabilities
Other Long Term Liabilities 114.24 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 0.00% vs -0.46% in Dec 2022

Annual - Fixed Assets
Fixed Assets 90.21 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 33.15% vs -1.81% in Dec 2022

Annual - Investments
Investments 6.87 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 13.55% vs 19.80% in Dec 2022

Annual - Current Assets
Current Assets 338.87 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is -9.57% vs 52.25% in Dec 2022